Risk factors for bone metastasis from renal cell cancer
暂无分享,去创建一个
Min Lan | Yang Zhou | Jiaming Liu | Xuan-Yin Chen | Shanhu Huang | Zhi-li Liu | Jia-Ming Liu | Wen-Zhao Chen | Zhi-Li Liu | Xuan-Yin Chen | Dong Hu | Shan-Hu Huang | Zhi-Hong Zhang | Min Lan | Yang Zhou | D. Hu | Wenzhao Chen | Zhi-Hong Zhang
[1] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[2] K. Junker,et al. High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor , 2014, Molecular Cancer.
[3] T. Jang,et al. Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach , 2017, Front. Oncol..
[4] R. Reis,et al. Expression of tyrosine kinase receptor AXL is associated with worse outcome of metastatic renal cell carcinomas treated with sunitinib. , 2018, Urologic oncology.
[5] William Hollingworth,et al. A systematic review of geographical variation in access to chemotherapy , 2015, BMC Cancer.
[6] 장윤희,et al. Y. , 2003, Industrial and Labor Relations Terms.
[7] M. Kunimatsu,et al. Human prostate cancer cells adhere specifically to hemoglobin: a possible role in bone-specific metastasis. , 2001, Cancer letters.
[8] J. Ying,et al. A meta-analysis survey of appropriate bone turnover markers in the detection of bone metastasis in lung cancer , 2017, International Journal of Clinical Oncology.
[9] F. Hamdy,et al. Tumour-derived alkaline phosphatase regulates tumour growth, epithelial plasticity and disease-free survival in metastatic prostate cancer , 2016, British Journal of Cancer.
[10] P. Kuo,et al. Bone Metastasis from Renal Cell Carcinoma , 2016, International journal of molecular sciences.
[11] M. Menon,et al. Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] R. Kapoor,et al. Renal cell carcinoma in India demonstrates early age of onset & a late stage of presentation , 2014, The Indian journal of medical research.
[13] H. You,et al. Autocrine and paracrine STIP1 signaling promote osteolytic bone metastasis in renal cell carcinoma , 2017, Oncotarget.
[14] S. Girgis,et al. Review of renal cell carcinoma and its common subtypes in radiology. , 2016, World journal of radiology.
[15] Joo Hoon Kim,et al. Bone alkaline phosphatase as a surrogate marker of bone metastasis in gastric cancer patients , 2016, BMC Cancer.
[16] J. Karam,et al. Role of targeted therapy in combination with surgery in renal cell carcinoma , 2016, International journal of urology : official journal of the Japanese Urological Association.
[17] C. Boudot,et al. Overexpression of a functional calcium-sensing receptor dramatically increases osteolytic potential of MDA-MB-231 cells in a mouse model of bone metastasis through epiregulin-mediated osteoprotegerin downregulation , 2017, Oncotarget.
[18] Janet E Brown,et al. Skeletal metastasis in renal cell carcinoma: current and future management options. , 2012, Cancer treatment reviews.
[19] S. Bavbek,et al. Prognostic factors associated with the response to sunitinib in patients with metastatic renal cell carcinoma. , 2013, Current oncology.
[20] Clinical characteristics and risk factors for developing bone metastases in patients with breast cancer , 2017, Scientific Reports.
[21] Ping Huang,et al. Serum calcium, alkaline phosphotase and hemoglobin as risk factors for bone metastases in bladder cancer , 2017, PloS one.
[22] H. Nishimatsu,et al. Prognostic factors for renal cell carcinoma with bone metastasis: who are the long-term survivors? , 2011, The Journal of urology.
[23] W. Brenner,et al. The role of extracellular calcium in bone metastasis , 2016, Journal of bone oncology.